Skip to main content
SpringerLink
Log in

Identification of Prognostic and Immune Characteristics of Two Lung Adenocarcinoma Subtypes Based on TRPV Channel Family Genes

  • Published:
The Journal of Membrane Biology Aims and scope Submit manuscript

Abstract

Lung adenocarcinoma (LUAD) is one of the deadliest malignant tumors worldwide. Transient receptor potential vanilloid (TRPV) channels take pivotal parts in many cancers, but their impact on LUAD remains unexplored. In this study, LUAD samples were classified into two subtypes according to the expression characteristics of TRPV1-6 genes, with LUAD subtype cluster2 exhibiting significantly higher survival rates than cluster1. Subsequently, analysis of differentially expressed genes (DEGs) was performed between cluster1 and cluster2, revealing enrichment of DEGs in channel activity and Ca2+ signaling pathways. We established a protein–protein interaction network based on DEGs and constructed a LUAD prognostic model by using Cox regression analysis based on genes corresponding to 170 protein nodes. The prognostic model demonstrated good predictive ability for patient prognosis, with higher survival rates observed in the low-risk (LR) group. The risk score was validated as an independent prognostic indicator, according to Cox regression analysis. A clinically applicable nomogram was plotted. Immunological analysis indicated that the LR and high-risk (HR) groups had varied proportions of immune cell infiltration. The immunotherapy prediction indicated that LUAD patients in LR group had a greater likelihood to benefit from immune checkpoint blockade therapy. Furthermore, we hypothesized that the expression patterns of feature genes in the LUAD model were related to the sensitivity to lung cancer therapeutic drugs TAS-6417 and Erlotinib. To sum up, our LUAD prognostic model possessed clinical applicability for prognosis and immunotherapy response prediction.

Graphical Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Data Availability

The data that support the findings of this study are available on request from the corresponding author.

References

  • Brown S, Banfill K, Aznar MC, Whitehurst P, Faivre Finn C (2019) The evolving role of radiotherapy in non-small cell lung cancer. Br J Radiol 92(1104):20190524

    Article  PubMed  PubMed Central  Google Scholar 

  • Chen C, Wu Y, Lu HL, Liu K, Qin X (2022) Identification of potential biomarkers of vascular calcification using bioinformatics analysis and validation in vivo. PeerJ 10:e13138

    Article  PubMed  PubMed Central  Google Scholar 

  • de Almeida AS, Bernardes LB, Trevisan G (2021) TRP channels in cancer pain. Eur J Pharmacol 904:174185

    Article  PubMed  Google Scholar 

  • Fan T, Li S, Xiao C, Tian H, Zheng Y, Liu Y, Li C, He J (2022) CCL20 promotes lung adenocarcinoma progression by driving epithelial-mesenchymal transition. Int J Biol Sci 18(11):4275–4288

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fang C, Dai L, Wang C, Fan C, Yu Y, Yang L, Deng H, Zhou Z (2021) Secretogranin II impairs tumor growth and angiogenesis by promoting degradation of hypoxia-inducible factor-1alpha in colorectal cancer. Mol Oncol 15(12):3513–3526

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gohara K, Okazaki A, Takeda Y, Iwasa K, Shibata K (2021) Complete remission of advanced lung adenocarcinoma with first-line pembrolizumab monotherapy: Two case reports. Respir Med Case Rep 33:101469

    PubMed  PubMed Central  Google Scholar 

  • Hasako S, Terasaka M, Abe N, Uno T, Ohsawa H, Hashimoto A, Fujita R, Tanaka K, Okayama T, Wadhwa R, Miyadera K, Aoyagi Y, Yonekura K, Matsuo K (2018) TAS6417, A Novel EGFR Inhibitor Targeting Exon 20 Insertion Mutations. Mol Cancer Ther 17(8):1648–1658

    Article  CAS  PubMed  Google Scholar 

  • Ito H, Nakayama H, Yokose T, Nagashima T, Morohoshi T, Tajiri M, Maehara T, Watanabe K, Arai H, Yamamoto T, Woo T, Nishii T, Ishikawa Y, Morita S, Masuda M (2020) A prophylaxis study of acute exacerbation of interstitial pneumonia after lung cancer surgery. Jpn J Clin Oncol 50(2):198–205

    Article  PubMed  Google Scholar 

  • Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, Li Z, Traugh N, Bu X, Li B, Liu J, Freeman GJ, Brown MA, Wucherpfennig KW, Liu XS (2018) Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med 24(10):1550–1558

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jiang H, Li Y, Wang T (2021) Comparison of Billroth I, Billroth II, and Roux-en-Y reconstructions following distal gastrectomy: a systematic review and network meta-analysis. Cir Esp (engl Ed) 99(6):412–420

    Article  PubMed  Google Scholar 

  • Jiang Y, Han D, Zhao Y, Zhang C, Shi X, Gu W (2022) Multi-omics analysis of the prognosis and biological function for TRPV channel family in clear cell renal cell carcinoma. Front Immunol 13:872170

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ju G, Yao Z, Zhao Y, Zhao X, Liu F (2023) Data mining on identifying diagnosis and prognosis biomarkers in head and neck squamous carcinoma. Sci Rep 13(1):10020

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kang HG, Kim SJ (2022) High Expression of Pregnancy Specific Beta-1-glycoprotein 1 Is Associated With Poor Gastric Cancer Prognosis. In Vivo 36(6):2700–2707

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kanugula AK, Adapala RK, Jamaiyar A, Lenkey N, Guarino BD, Liedtke W, Yin L, Paruchuri S, Thodeti CK (2021) Endothelial TRPV4 channels prevent tumor growth and metastasis via modulation of tumor angiogenesis and vascular integrity. Angiogenesis 24(3):647–656

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kawashima Y, Fukuhara T, Saito H, Furuya N, Watanabe K, Sugawara S, Iwasawa S, Tsunezuka Y, Yamaguchi O, Okada M, Yoshimori K, Nakachi I, Seike M, Azuma K, Kurimoto F, Tsubata Y, Fujita Y, Nagashima H, Asai G, Watanabe S, Miyazaki M, Hagiwara K, Nukiwa T, Morita S, Kobayashi K, Maemondo M (2022) Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial. Lancet Respir Med 10(1):72–82

    Article  CAS  PubMed  Google Scholar 

  • Khattar V, Wang L, Peng JB (2022) Calcium selective channel TRPV6: Structure, function, and implications in health and disease. Gene 817:146192

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kim H, Barua A, Huang L, Zhou T, Bolaji M, Zachariah S, Mitra A, Jung SY, He B, Feng Q (2023) The cancer testis antigen TDRD1 regulates prostate cancer proliferation by associating with the snRNP biogenesis machinery. Oncogene 42(22):1821–1831

    Article  CAS  PubMed  Google Scholar 

  • Lewis WD, Lilly S, Jones KL (2020) Lymphoma: Diagnosis and Treatment. Am Fam Physician 101(1):34–41

    PubMed  Google Scholar 

  • Li G, Luo Q, Wang X, Zeng F, Feng G, Che G (2022a) Deep learning reveals cuproptosis features assist in predict prognosis and guide immunotherapy in lung adenocarcinoma. Front Endocrinol (lausanne) 13:970269

    Article  PubMed  Google Scholar 

  • Li X, Li H, Li Z, Wang T, Yu D, Jin H, Cao Y (2022b) TRPV3 promotes the angiogenesis through HIF-1alpha-VEGF signaling pathway in A549 cells. Acta Histochem 124(8):151955

    Article  CAS  PubMed  Google Scholar 

  • Liu G, Pan Y, Li Y, Xu H (2020) lncRNA and mRNA signature for prognosis prediction of glioblastoma. Future Oncol 16(13):837–848

    Article  CAS  PubMed  Google Scholar 

  • Liu X, Li J, Wang Q, Bai L, Xing J, Hu X, Li S, Li Q (2022) Analysis on heterogeneity of hepatocellular carcinoma immune cells and a molecular risk model by integration of scRNA-seq and bulk RNA-seq. Front Immunol 13:1012303

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Luo D, Liao S, Liu Y, Lin Y, Li Y, Liao X (2022) Holliday Cross-Recognition Protein HJURP: Association With the Tumor Microenvironment in Hepatocellular Carcinoma and With Patient Prognosis. Pathol Oncol Res 28:1610506

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP (2018) Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res 28(11):1747–1756

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Muller I, Alt P, Rajan S, Schaller L, Geiger F, Dietrich A (2022) Transient Receptor Potential (TRP) Channels in Airway Toxicity and Disease: An Update. Cells 11(18):2907

    Article  PubMed  PubMed Central  Google Scholar 

  • Naccache JM, Jouneau S, Didier M, Borie R, Cachanado M, Bourdin A, Reynaud-Gaubert M, Bonniaud P, Israel-Biet D, Prevot G, Hirschi S, Lebargy F, Marchand-Adam S, Bautin N, Traclet J, Gomez E, Leroy S, Gagnadoux F, Riviere F, Bergot E, Gondouin A, Blanchard E, Parrot A, Blanc FX, Chabrol A, Dominique S, Gibelin A, Tazi A, Berard L, Brillet PY, Debray MP, Rousseau A, Kerjouan M, Freynet O, Dombret MC, Gamez AS, Nieves A, Beltramo G, Pastre J, Le Borgne-Krams A, Degot T, Launois C, Plantier L, Wemeau-Stervinou L, Cadranel J, Chenivesse C, Valeyre D, Crestani B, Cottin V, Simon T, Nunes H, Investigators E, OrphaLung N (2022) Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med 10(1):26–34

    Article  CAS  PubMed  Google Scholar 

  • Nie Y, Feng F, Luo W, Sanders AJ, Zhang Y, Liang J, Chen C, Feng W, Gu W, Liao W, Wang W, Chen J, Zhang L, Jiang WG, Li J (2022) Overexpressed transient receptor potential vanilloid 1 (TRPV1) in lung adenocarcinoma harbours a new opportunity for therapeutic targeting. Cancer Gene Ther 29(10):1405–1417

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rattila S, Kleefeldt F, Ballesteros A, Beltrame JS, Ribeiro ML, Ergün S, Dveksler G (2020) Pro-angiogenic effects of pregnancy-specific glycoproteins in endothelial and extravillous trophoblast cells. Reproduction 160(5):737–750

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Reck M, Remon J, Hellmann MD (2022) First-Line Immunotherapy for Non-Small-Cell Lung Cancer. J Clin Oncol 40(6):586–597

    Article  CAS  PubMed  Google Scholar 

  • Sasase T, Fatchiyah F, Ohta T (2022) Transient receptor potential vanilloid (TRPV) channels: Basal properties and physiological potential. Gen Physiol Biophys 41(3):165–190

    Article  CAS  PubMed  Google Scholar 

  • Shen ML, Xiao A, Yin SJ, Wang P, Lin XQ, Yu CB, He GH (2019) Associations between UGT2B7 polymorphisms and cancer susceptibility: A meta-analysis. Gene 706:115–123

    Article  CAS  PubMed  Google Scholar 

  • Siveen KS, Prabhu KS, Parray AS, Merhi M, Arredouani A, Chikri M, Uddin S, Dermime S, Mohammad RM, Steinhoff M, Janahi IA, Azizi F (2019) Evaluation of cationic channel TRPV2 as a novel biomarker and therapeutic target in Leukemia-Implications concerning the resolution of pulmonary inflammation. Sci Rep 9(1):1554

    Article  PubMed  PubMed Central  Google Scholar 

  • Song Y, Zhou K, Zou D, Zhou J, Hu J, Yang H, Zhang H, Ji J, Xu W, Jin J, Lv F, Feng R, Gao S, Guo H, Zhou L, Elstrom R, Huang J, Novotny W, Wei R, Zhu J (2020) Treatment of Patients with Relapsed or Refractory Mantle-Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton’s Tyrosine Kinase. Clin Cancer Res 26(16):4216–4224

    Article  CAS  PubMed  Google Scholar 

  • Succony L, Rassl DM, Barker AP, McCaughan FM, Rintoul RC (2021) Adenocarcinoma spectrum lesions of the lung: Detection, pathology and treatment strategies. Cancer Treat Rev 99:102237

    Article  CAS  PubMed  Google Scholar 

  • Sun D, Zhu Y, Zhao H, Bian T, Li T, Liu K, Feng L, Li H, Hou H (2021) Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis. Cell Oncol (dordr) 44(5):1019–1034

    Article  CAS  PubMed  Google Scholar 

  • Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71(3):209–249

    Article  PubMed  Google Scholar 

  • Uhlig R, Contreras H, Weidemann S, Gorbokon N, Menz A, Buscheck F, Luebke AM, Kluth M, Hube-Magg C, Hinsch A, Hoflmayer D, Fraune C, Moller K, Bernreuther C, Lebok P, Sauter G, Wilczak W, Izbicki J, Perez D, Schrader J, Steurer S, Burandt E, Krech R, Dum D, Krech T, Marx A, Simon R, Minner S, Jacobsen F, Clauditz TS (2022) Carboxypeptidase A1 (CPA1) Immunohistochemistry Is Highly Sensitive and Specific for Acinar Cell Carcinoma (ACC) of the Pancreas. Am J Surg Pathol 46(1):97–104

    Article  PubMed  Google Scholar 

  • Wang X, Li G, Zhang Y, Li L, Qiu L, Qian Z, Zhou S, Wang X, Li Q, Zhang H (2022) Pan-Cancer Analysis Reveals Genomic and Clinical Characteristics of TRPV Channel-Related Genes. Front Oncol 12:813100

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang L, Shen J, Wang Y, Bi J (2023) Identification of fatty acid metabolism-based molecular subtypes and prognostic signature to predict immune landscape and guide clinical drug treatment in renal clear cell carcinoma. Int Immunopharmacol 116:109735

    Article  CAS  PubMed  Google Scholar 

  • Wu L, Zhou Y, Guan Y, Xiao R, Cai J, Chen W, Zheng M, Sun K, Chen C, Huang G, Zhang X, Qian Z, Shen S (2021) Seven Genes Associated With Lymphatic Metastasis in Thyroid Cancer That Is Linked to Tumor Immune Cell Infiltration. Front Oncol 11:756246

    Article  CAS  PubMed  Google Scholar 

  • Yao S, Huang HY, Han X, Ye Y, Qin Z, Zhao G, Li F, Hu G, Hu L, Ji H (2019) Keratin 14-high subpopulation mediates lung cancer metastasis potentially through Gkn1 upregulation. Oncogene 38(36):6354–6369

    Article  CAS  PubMed  Google Scholar 

  • Zhao W, Liu M, Zhang M, Wang Y, Zhang Y, Wang S, Zhang N (2021) Effects of Inflammation on the Immune Microenvironment in Gastric Cancer. Front Oncol 11:690298

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhao G, Song D, Wu J, Yang S, Shi S, Cui X, Ren H, Zhang B (2022) Identification of OTUD6B as a new biomarker for prognosis and immunotherapy by pan-cancer analysis. Front Immunol 13:955091

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhao R, Wang W, Pan L, Lv X, He Y, Lian W, Ma Y, Zhang X, Yu R, Zhao S, Guo X, Huang T, Peng M (2023) The prognostic value and response to immunotherapy of immunogenic cell death-associated genes in breast cancer. Front Oncol 13:1047973

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhu J, Lu Q, Li B, Li H, Wu C, Li C, Jin H (2021) Potential of the cell-free blood-based biomarker uroplakin 2 RNA to detect recurrence after surgical resection of lung adenocarcinoma. Oncol Lett 22(1):520

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zuidscherwoude M, van Goor MK, Roig SR, Thijssen N, van Erp M, Fransen J, van der Wijst J, Hoenderop JG (2023) Functional basis for calmodulation of the TRPV5 calcium channel. J Physiol 601(4):859–878

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

Not applicable.

Author information

Authors and Affiliations

  1. Department of Cardiothoracic Surgery, Jingmen People’s Hospital, No.39 Xiangshan Avenue, Jingmen City, 448000, Hubei Province, China

    Jianhua Jiang, Pengchao Zheng & Lei Li

Authors
  1. Jianhua Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pengchao Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

JJ: conception and design. LL, PZ: administrative support. LL, PZ: collection and assembly of data. JJ: data analysis and interpretation. JJ: manuscript writing. All authors: final approval of manuscript.

Corresponding authors

Correspondence to Pengchao Zheng or Lei Li.

Ethics declarations

Conflict of interest

All authors declare that they have no potential conflicts of interest.

Ethical Approval

Not applicable.

Consent to Participate

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary material 1 (XLSX 61.9 kb)

Supplementary material 2 (XLS 24.0 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jiang, J., Zheng, P. & Li, L. Identification of Prognostic and Immune Characteristics of Two Lung Adenocarcinoma Subtypes Based on TRPV Channel Family Genes. J Membrane Biol 257, 115–129 (2024). https://doi.org/10.1007/s00232-023-00300-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00232-023-00300-1

Keywords

Search

Navigation